官方服务：
资源简介：
a rna-seq study that testing an antineoplastic drug on mouse
应用场景：
创建时间：
2025-05-01
相关数据集
Discovery of a Pyrimidinedione Derivative as a Potent and Orally Bioavailable Axl Inhibitor
The receptor tyrosine kinase Axl plays important roles in promoting cancer progression, metastasis, and drug resistance and has been identified as a promising target for anticancer therapeutics. We us
NIAID Data Ecosystem50
Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity
TTK is an essential spindle assembly checkpoint enzyme in many organisms. It plays a central role in tumor cell proliferation and is aberrantly overexpressed in a wide range of tumor types. We recentl
Figshare2021-08-30 更新30
Design, Synthesis and Antitumor Activity of a Novel Class of SHP2 Allosteric Inhibitors with a Furanyl Amide-Based Scaffold
SHP2 plays a critical role in modulating tumor growth and PD-1-related signaling pathway, thereby serving as an attractive antitumor target. To date, no antitumor drugs targeting SHP2 have been approv
NIAID Data Ecosystem20
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins. Homo sapiens
Primary breast cancer xenografts Overall design: Two primary xenografts with different treatments in triplicate
NIAID Data Ecosystem40
Discovery of Quinazoline-2,4(1 H ,3 H )‑dione Derivatives Containing 3‑Substituted Piperizines as Potent PARP-1/2 InhibitorsDesign, Synthesis, In Vivo Antitumor Activity, and X‑ray Crystal Structure Analysis
Inhibiting PARP-1/2 offered an important arsenal for cancer treatments via interfering with DNA repair of cancer cells. Novel PARP-1/2 inhibitors were designed by capitalizing on methyl- or ethyl-subs
NIAID Data Ecosystem30
